Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-258859
Filing Date
2024-11-14
Accepted
2024-11-14 17:52:56
Documents
2
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCMOEZ KASSAMTONY MOORE

Document Format Files

Seq Description Document Type Size
1 SC 13G d901189dsc13g.htm SC 13G 116481
2 EX-99.1 d901189dex991.htm EX-99.1 7493
  Complete submission text file 0001193125-24-258859.txt   125930
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Subject) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90218 | Film No.: 241464811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)